Schein Ps
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Glioma Diagnosis and Treatment
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
- Co-authors
- VT Jr DeVita (2 shared papers)P. M. Banks (2 shared papers)PA Jr Bunn (2 shared papers)Macdonald Js (5 shared papers)J. Whang‐Peng (1 shared paper)RC Young (2 shared papers)V T DeVita (2 shared papers)Canellos Gp (2 shared papers)
- Journals
- Blood (4 papers)PubMed (20 papers)
- Partner nations
- United StatesVietnam
In The Last Decade
Schein Ps
24 papers receiving 461 citations
Peers
Comparison fields: 5 of 65
- Genetics 167
- Hematology 110
- Neurology 125
- Pathology and Forensic Medicine 143
- Oncology 184
Countries citing papers authored by Schein Ps
This map shows the geographic impact of Schein Ps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Schein Ps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Schein Ps more than expected).
Fields of papers citing papers by Schein Ps
This network shows the impact of papers produced by Schein Ps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Schein Ps. The network helps show where Schein Ps may publish in the future.
Co-authors
The 25 scholars most cited alongside Schein Ps, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1976 | 201 | |
| 2 | Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters. | 1976 | 60 |
| 3 | 1976 | 58 | |
| 4 | Probable clonal origin of acute myeloblastic leukemia following radiation and chemotherapy of colon cancer. | 1978 | 54 |
| 5 | 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU. | 1976 | 34 |
| 6 | Contributions of nitrosoureas to cancer treatment. | 1986 | 31 |
| 7 | Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, measurable adenocarcinoma of the lung and stomach. | 1986 | 17 |
| 8 | Phase II study of sequential methotrexate-5-FU therapy in advanced measurable colorectal cancer. | 1982 | 16 |
| 9 | Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent. | 1976 | 16 |
| 10 | Chemotherapy of colorectal carcinoma. | 1976 | 12 |
| 11 | Clinical experiences with extracorporeal immunoperfusion of plasma from cancer patients. | 1984 | 9 |
| 12 | Use of peritoneoscopy for initial staging and posttherapy evaluation of patients with ovarian carcinoma. | 1975 | 8 |
| 13 | Laetrile toxicity: a report of two patients. | 1978 | 8 |
| 14 | Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer. | 1978 | 8 |
| 15 | 1976 | 7 | |
| 16 | CAMP (cyclophosphamide, doxorubicin, methotrexate, and procarbazine) for epidermoid and large cell anaplastic carcinoma of the lung. | 1981 | 5 |
| 17 | Phase II trial of mitoxantrone in advanced colorectal cancer. | 1982 | 4 |
| 18 | Estramustine: historical background and preclinical trials. | 1983 | 4 |
| 19 | 1976 | 2 | |
| 20 | Phase II study of PCNU in colorectal carcinoma. | 1982 | 2 |
About Schein Ps
Schein Ps is a scholar working on Oncology, Genetics, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health, having authored 24 papers that have together received 563 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Colorectal Cancer Treatments and Studies (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Gastric Cancer Management and Outcomes (3 papers), Acute Myeloid Leukemia Research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Genetics (167 citations), Hematology (110 citations), Neurology (125 citations), Pathology and Forensic Medicine (143 citations) and Oncology (184 citations). Schein Ps has collaborated with scholars based in United States and Vietnam. Frequent co-authors include VT Jr DeVita, P. M. Banks, PA Jr Bunn, Macdonald Js, J. Whang‐Peng, RC Young, V T DeVita, Canellos Gp, B A Chabner and RJ Jacobson. Their work appears in journals such as Blood and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.